Tarsus Pharmaceuticals, Inc. TARS Common stock, shares issued (in shares)
Common stock, shares issued (in shares) at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s common stock, shares issued (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s common stock, shares issued (in shares)?
- Tarsus Pharmaceuticals, Inc. (TARS) reported common stock, shares issued (in shares) of $43.02M in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s common stock, shares issued (in shares) changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s common stock, shares issued (in shares) increased by 2.4% year-over-year, from $42M to $43.02M.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s common stock, shares issued (in shares)?
- Over 5 years (2020 to 2025), Tarsus Pharmaceuticals, Inc.'s common stock, shares issued (in shares) has grown at a 15.7% compound annual growth rate (CAGR), from $20.5M to $42.55M.